Financial news API & MCP server

Financial newsfor AI agents.

Stock market news and SEC filing updates, scored for relevance and sentiment. Available through a REST API and MCP server.

10,000+
Articles scanned daily

Crawled and deduplicated across the open web.

6,900+
Sources monitored

Distinct publisher domains scanned in the last 30 days.

<1 in 5
Makes the feed

Only the best clear the relevance floor.

~6 min
SEC filing to feed

Median from EDGAR publication to an enriched, ticker-tagged row.

Top stories

All stories →
M&AOCT 229 / 10

EQT agrees to acquire Qiagen in an all‑cash €46.50‑per‑share takeover

Swedish private‑equity firm EQT announced an all‑cash offer of €46.50 per share for Qiagen, valuing the company at roughly €9.6 billion. The board of Qiagen unanimously approved the transaction, which carries an 8.6% premium to the last closing price and a 40.3% premium to the pre‑rumor price. The deal is subject to shareholder approval, regulatory clearances and is expected to close in mid‑2027, after which Qiagen will be delisted from the Frankfurt and NYSE exchanges.

$EQT$KKR$MYGN$QGEN21 sources · 11 publishersNew sources since summary
Delivery

News alerts in Telegram, email, or a webhook.

Set up alerts →
$LRCXLow

LRCX Stock Tumbles Overnight Despite Record Profits: Supply Snags Put Sales On Hold As China Slowdown Looms

Lam Research (LRCX) reported record profits but saw its stock tumble due to supply chain issues delaying sales. CEO Tim Archer expects these delays to be temporary. The company anticipates a significant drop in China's revenue share in December. Lam forecasts strong semiconductor investment driven by AI demand, with 2026 systems revenue expected to grow over 40%. The company raised its Aether-related revenue forecast to $2.5 billion by 2030.

$WVELow

WAVE Life Sciences Highlights Obesity Data, FDA-Aligned RNA Editing Path

WAVE Life Sciences (WVE) presented obesity data, highlighting reductions in visceral and subcutaneous fat. The company's Phase II-A study of WVE-007 is underway, assessing obesity and cardiometabolic outcomes. Wave also aligned with the FDA on a trial design for its alpha-1 antitrypsin deficiency program, aiming for a two-year clinical trial with a potential interim analysis at one year.

Stock news API with sentiment and relevance scores

The same scored news feed that powers AlphAI is available as a REST API, and as an MCP server for Claude Desktop, Cursor, and any other agent host. Articles arrive enriched and linked to tickers in real time.

  • Real-time + historical news
  • Per-ticker filters and search
  • Relevance-scored 1–10
  • Free tier + paid scale

Dropping it into an existing stack? The Python and n8n quick starts are copy-paste.

curl https://api.alphai.io/api/news/ \
  -H "Authorization: Bearer ${ALPHAI_API_KEY}" \
  -G -d "symbol=NVDA"

# → {
#   "results": [{
#     "original": {
#       "title": "Nvidia export curbs tighten...",
#       "summary": "The White House is expected to...",
#       "time_published": "2026-04-18T14:32:00Z"
#     },
#     "enrichment": {
#       "category": "macro",
#       "tickers": ["NVDA"],
#       "relevance_score": 9
#     }
#   }, ...],
#   "next_cursor": "MjAyNi0wNC0xOFQxNDozMjowMHw0Mg=="
# }

Three plans. One feed.

Free reads the feed and probes the APIs. Paid plans drop the ads and scale up the rate.

Free

$0forever
  • Unlimited articles on the website
  • REST + MCP: 20 / min · 100 / day each, 1 API key
  • Sponsored placements visible
Start for free

Basic

$2.99$7.99/month
  • No ads, unlimited watchlist
  • Daily digest of ticker alerts
  • REST API: 60 / min · 10,000 / day, 1 key
  • MCP server: 60 / min · 10,000 / day
Get started

Pro

$9.99$24.99/month
  • Everything in Basic
  • REST API: 150 / min · 100,000 / day, 5 keys
  • MCP server: 150 / min · 100,000 / day + bulk
Get started

Subscribe now and keep this rate for as long as you stay subscribed. We will not raise it for you.

Don’t want to watch the feed? Follow a ticker and we’ll deliver a daily digest of everything that clears your relevance bar, so you don’t have to check back.

Set up alerts